SCHEMBL24041863

SCHEMBL24041863

COc1ccc(CCOc2ccc(CCn3cnc4ccccc43)cc2)cc1

nearest known ligand 0.62

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ HTT P42858 5/20 0.62
▸ LTA4H P09960 1/20 0.62
▸ L3MBTL1 Q9Y468 1/20 0.59
▸ SMN1; SMN2 Q16637 8/20 0.58
▸ LMNA P02545 4/20 0.58
▸ TSHR P16473 2/20 0.58
▸ NPSR1 Q6W5P4 1/20 0.58
▸ KMT2A Q03164 2/20 0.57
▸ MEN1 O00255 1/20 0.57
▸ ALOX15 P16050 1/20 0.56
▸ CSF1R P07333 1/20 0.53
▸ TDP1 Q9NUW8 1/20 0.51
▸ FFAR1 O14842 1/20 0.49
▸ PPARG P37231 1/20 0.49
▸ MAPT P10636 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24041782 0.94 HTT (0.60) HTTLTA4HL3MBTL1SMN1; SMN2LMNA
SCHEMBL24041763 0.94 HTT (0.70) HTTLTA4HL3MBTL1SMN1; SMN2LMNA
SCHEMBL24041743 0.91 HTT (0.76) HTTLTA4HL3MBTL1SMN1; SMN2LMNA
SCHEMBL24041770 0.91 LTA4H (0.58) HTTLTA4HL3MBTL1SMN1; SMN2LMNA
SCHEMBL24041749 0.91 HTT (0.57) HTTLTA4HL3MBTL1SMN1; SMN2LMNA
SCHEMBL24041830 0.90 HTT (0.62) HTTLTA4HL3MBTL1SMN1; SMN2LMNA
SCHEMBL24041804 0.89 HTT (0.63) HTTLTA4HL3MBTL1SMN1; SMN2LMNA
SCHEMBL24041777 0.88 HTT (0.62) HTTLTA4HL3MBTL1SMN1; SMN2LMNA
SCHEMBL24041832 0.87 LTA4H (0.56) HTTLTA4HL3MBTL1SMN1; SMN2LMNA
SCHEMBL24041750 0.87 L3MBTL1 (0.74) HTTLTA4HL3MBTL1SMN1; SMN2LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116194439-B SOCE inhibitors and therapeutic uses thereof 国家医疗保健研究所 2025-04-08 — — CN disclosed
CN-116194439-A SOCE inhibitors and therapeutic uses thereof 国家医疗保健研究所 2023-05-30 — — CN disclosed
WO-2021233994-A1 SOCE INHIBITORS AND THERAPEUTIC USES THEREOF INSERM (Institut National de la Santé et de la Recherche Médicale) (FR) 2021-11-25 — — WO disclosed
EP-3912972-A1 SOCE INHIBITORS AND THERAPEUTIC USES THEREOF Centre Hospitalier Régional et Universitaire de Brest (FR) 2021-11-24 — — EP disclosed
Send feedback